| Views | |
|---|---|
| Development and characterisation of buparvaquone nanosuspensions for pulmonary delivery in the treatment of Pneumocystis pneumonia | 353 |
| November 2024 | December 2024 | January 2025 | February 2025 | March 2025 | April 2025 | May 2025 | |
|---|---|---|---|---|---|---|---|
| Development and characterisation of buparvaquone nanosuspensions for pulmonary delivery in the treatment of Pneumocystis pneumonia | 6 | 8 | 3 | 7 | 21 | 9 | 3 |
| Views | |
|---|---|
| 3_Chapter3_Materials_Methods.pdf | 275 |
| 6_Chapter6_References.pdf | 274 |
| 1_Chapter1_Introduction_aims_objectives.pdf | 203 |
| 7_Chapter7_Appendices_Aknowledgements.pdf | 171 |
| 0_Title_Index.pdf | 168 |
| 2_Chapter2_Literature_review.pdf | 134 |
| 4_Chapter4_Results_Discussions.pdf | 117 |
| 5_Chapter5_Summary_Zusammenfassung.pdf | 89 |
